At the 2024 Society for Investigative Dermatology Annual Meeting held in Dallas, Texas, Dr. Alice Gottlieb, renowned dermatologist and rheumatologist from the Icahn School of Medicine at Mount Sinai, underscored the critical role of multidisciplinary care in managing psoriatic disease. Dr. Gottlieb’s extensive research and pioneering work in dermatology and rheumatology have significantly influenced the treatment landscape for conditions like psoriasis.
Dr. Gottlieb highlighted her groundbreaking research demonstrating the efficacy of TNF blockers in clearing psoriasis, which she believes paved the way for the development of biologics in treating psoriasis and related conditions such as atopic dermatitis and alopecia areata.
Central to her presentation was the importance of dermatologists in detecting and managing psoriatic arthritis, a condition that affects up to 30% of psoriasis patients. Early diagnosis, she stressed, is crucial as delays can lead to worsened outcomes, including joint damage and reduced quality of life.
“Psoriatic arthritis can be missed in up to 41% of cases by dermatologists,” noted Dr. Gottlieb, emphasizing the need for vigilant screening during routine dermatological visits. She introduced practical tools like the PEST and PsAID assessments, available through the GRAPPA app, which aid in identifying patients at risk for psoriatic arthritis and assessing disease control.
Dr. Gottlieb outlined an innovative approach implemented at Mount Sinai Union Square, where these assessments are integrated into electronic medical records. This system alerts healthcare providers to patients potentially requiring rheumatological evaluation based on their assessment scores, ensuring timely intervention.
During her lecture, Dr. Gottlieb also reviewed FDA-approved treatments for psoriatic arthritis and discussed ongoing research into the potential benefits of biologic therapies in preventing its onset.
In conclusion, Dr. Gottlieb encouraged healthcare professionals to participate in upcoming educational opportunities such as the Masterclass in Dermatology and specialized training sessions for physician assistants and nurse practitioners, emphasizing the importance of interdisciplinary collaboration in optimizing patient care.
Her comprehensive presentation at the conference underscored her commitment to advancing the field of dermatology and rheumatology, particularly in improving outcomes for patients with psoriatic disease.
This article is based on Dr. Alice Gottlieb’s presentation at the 2024 Society for Investigative Dermatology Annual Meeting and her contributions to the field of dermatology and rheumatology.
Related Topics:
